Cargando…

Retinal gene therapy in X-linked retinitis pigmentosa caused by mutations in RPGR: Results at 6 months in a first in human clinical trial

Retinal gene therapy has shown great promise in treating retinitis pigmentosa (RP), a primary photoreceptor degeneration that leads to severe sight loss in young people(1,2,3,4,5,6). Here we report the first in human Phase I/II dose escalation clinical trial for X-linked RP caused by mutations in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cehajic-Kapetanovic, Jasmina, Xue, Kanmin, de la Camara, Cristina Martinez-Fernandez, Nanda, Anika, Davies, Alexandra, Wood, Laura J, Salvetti, Anna Paola, Fischer, M Dominik, Aylward, James W, Barnard, Alun R, Jolly, Jasleen K, Luo, Edmond, Lujan, Brandon J, Ong, Tuyen, Girach, Aniz, Black, Graeme CM, Gregori, Ninel Z, Davis, Janet L, Rosa, Potyra R, Lotery, Andrew J, Lam, Byron L, Stanga, Paulo E, MacLaren, Robert E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104347/ https://www.ncbi.nlm.nih.gov/pubmed/32094925 http://dx.doi.org/10.1038/s41591-020-0763-1

Ejemplares similares

Characterizing Visual Fields in RPGR Related Retinitis Pigmentosa Using Octopus Static-Automated Perimetry
por: Buckley, Thomas M. W., et al.
Publicado: (2022)

Microperimetry as an Outcome Measure in RPGR-associated Retinitis Pigmentosa Clinical Trials
por: Taylor, Laura J., et al.
Publicado: (2023)

Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations
por: von Krusenstiern, Lenore, et al.
Publicado: (2023)

Low Luminance Visual Acuity and Low Luminance Deficit in Choroideremia and RPGR-Associated Retinitis Pigmentosa
por: Wood, Laura J., et al.
Publicado: (2021)

Molecular Strategies for RPGR Gene Therapy
por: Cehajic Kapetanovic, Jasmina, et al.
Publicado: (2019)

Genome-Editing Strategies for Treating Human Retinal Degenerations
por: Quinn, Joel, et al.
Publicado: (2021)

Gene-agnostic therapeutic approaches for inherited retinal degenerations
por: John, Molly C., et al.
Publicado: (2023)

Codon-Optimized RPGR Improves Stability and Efficacy of AAV8 Gene Therapy in Two Mouse Models of X-Linked Retinitis Pigmentosa
por: Fischer, M. Dominik, et al.
Publicado: (2017)

Comparing Cone Structure and Function in RHO- and RPGR-Associated Retinitis Pigmentosa
por: Foote, Katharina G., et al.
Publicado: (2020)

Microperimetry Hill of Vision and Volumetric Measures of Retinal Sensitivity
por: Josan, Amandeep Singh, et al.
Publicado: (2021)

Impaired glutamylation of RPGR(ORF15) underlies the cone-dominated phenotype associated with truncating distal ORF15 variants
por: Cehajic-Kapetanovic, Jasmina, et al.
Publicado: (2022)

Molecular Therapies for Choroideremia
por: Cehajic Kapetanovic, Jasmina, et al.
Publicado: (2019)

Novel mutations of RPGR in Chinese families with X-linked retinitis pigmentosa
por: Zhang, Zhimeng, et al.
Publicado: (2019)

Visual Acuity by Decade in 139 Males with RPGR-Associated Retinitis Pigmentosa
por: De Silva, Samantha R., et al.
Publicado: (2023)

Analysis of imaging biomarkers and retinal nerve fiber layer thickness in RPGR-associated retinitis pigmentosa
por: Birtel, Theresa H., et al.
Publicado: (2021)

Exploring the Variable Phenotypes of RPGR Carrier Females in Assessing Their Potential for Retinal Gene Therapy
por: Nanda, Anika, et al.
Publicado: (2018)

Novel Mutations of RPGR in Chinese Retinitis Pigmentosa Patients and the Genotype-Phenotype Correlation
por: Yang, Liping, et al.
Publicado: (2014)

Spectrum of Disease Severity in Patients With X-Linked Retinitis Pigmentosa Due to RPGR Mutations
por: Di Iorio, Valentina, et al.
Publicado: (2020)

X-Linked Retinitis Pigmentosa Caused by Non-Canonical Splice Site Variants in RPGR
por: Kortüm, Friederike, et al.
Publicado: (2021)

Analysis of RP2 and RPGR Mutations in Five X-Linked Chinese Families with Retinitis Pigmentosa
por: Jiang, Jingjing, et al.
Publicado: (2017)

Compound dominant-null heterozygosity in a family with RP1-related retinal dystrophy
por: Buckley, Thomas M.W., et al.
Publicado: (2022)

Photoreceptor Rescue by an Abbreviated Human RPGR Gene in a Murine Model of X-linked Retinitis Pigmentosa
por: Pawlyk, Basil S., et al.
Publicado: (2015)

Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa
por: Edwards, Thomas L., et al.
Publicado: (2018)

Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa
por: Orlans, Harry O., et al.
Publicado: (2021)

Novel splice receptor-site mutation of RPGR in a Chinese family with X-linked retinitis pigmentosa
por: Wang, Jing, et al.
Publicado: (2018)

Identification of the RPGR Gene Pathogenic Variants in a Cohort of Polish Male Patients with Retinitis Pigmentosa Phenotype
por: Nowomiejska, Katarzyna, et al.
Publicado: (2023)

Correlation Between Fundus Autofluorescence Pattern and Retinal Function on Microperimetry in Choroideremia
por: Poli, Federica E., et al.
Publicado: (2023)

Chemogenetic Activation of Melanopsin Retinal Ganglion Cells Induces Signatures of Arousal and/or Anxiety in Mice
por: Milosavljevic, Nina, et al.
Publicado: (2016)

Interaction of retinitis pigmentosa GTPase regulator (RPGR) with RAB8A GTPase: implications for cilia dysfunction and photoreceptor degeneration
por: Murga-Zamalloa, Carlos A., et al.
Publicado: (2010)

Functional Analysis of a Novel, Non-Canonical RPGR Splice Variant Causing X-Linked Retinitis Pigmentosa
por: Koller, Samuel, et al.
Publicado: (2023)

AAV Induced Expression of Human Rod and Cone Opsin in Bipolar Cells of a Mouse Model of Retinal Degeneration
por: McClements, Michelle E., et al.
Publicado: (2021)

Candidate Genetic Modifiers for RPGR Retinal Degeneration
por: Appelbaum, Tatyana, et al.
Publicado: (2020)

Allelic Heterogeneity and Genetic Modifier Loci Contribute to Clinical Variation in Males with X-Linked Retinitis Pigmentosa Due to RPGR Mutations
por: Fahim, Abigail T., et al.
Publicado: (2011)

Clinical and Molecular Characterization of PROM1-Related Retinal Degeneration
por: Cehajic-Kapetanovic, Jasmina, et al.
Publicado: (2019)

The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients
por: Vaidya, Anil, et al.
Publicado: (2014)

RPGR isoform imbalance causes ciliary defects due to exon ORF15 mutations in X-linked retinitis pigmentosa (XLRP)
por: Moreno-Leon, Laura, et al.
Publicado: (2020)

Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy
por: Chandler, Laurel C., et al.
Publicado: (2020)

Glycosidic enzymes enhance retinal transduction following intravitreal delivery of AAV2
por: Cehajic-Kapetanovic, Jasmina, et al.
Publicado: (2011)

Transcorneal electrical stimulation for the treatment of retinitis pigmentosa: results from the TESOLAUK trial
por: Wagner, Siegfried K, et al.
Publicado: (2017)

The carboxyl terminal mutational hotspot of the ciliary disease protein RPGR(ORF15) (retinitis pigmentosa GTPase regulator) is glutamylated in vivo
por: Rao, Kollu N., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_et7kfv3ru6ath7esmfgqghbk6i